Clinical Trial Update: A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 study evaluating retatrutide's effects on renal function in adults with overweight/obesity and chronic kidney disease, with or without type 2 diabetes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Retatrutide (retatrutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight or Obesity, CKD | Phase 2 | Status: COMPLETED